AstraZeneca and Oxford University partner on Covid-19 vaccine

30th April 2020 (Last Updated April 30th, 2020 11:56)

AstraZeneca has signed an agreement with the University of Oxford to develop and distribute the university’s Covid-19 vaccine candidate, ChAdOx1 nCoV-19.

As part of the collaboration, AstraZeneca will carry out the development and global manufacturing and distribution of the Covid-19 vaccine.

Read the full article here